Results 61 to 70 of about 11,148 (154)

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 377-385, February 2026.
HPV vaccination in women undergoing active surveillance for CIN2 does not offer a protective effect against progression to CIN3+. Women should be informed that vaccination is not a substitute for clinical follow‐up and should be encouraged to adhere to recommended surveillance and treatment protocols Abstract Introduction Human papillomavirus (HPV ...
Dina O. Eriksen   +8 more
wiley   +1 more source

Rare phalanges soft tissue and bony metastasis in vulvar squamous cell carcinoma: Case report

open access: yesGynecologic Oncology Reports
Vulvar cancer accounts for 0.3 % of new cancer cases within the Unites States. Metastatic vulvar cancer with disease beyond the pelvis is rare and has a poor prognosis. Data on primary treatment including systemic treatments for distant metastatic vulvar
Landon Foulger   +3 more
doaj   +1 more source

Synergistic associations of metformin and GLP‐1 receptor agonist use with adiposity‐related cancer incidence in people living with type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 946-959, February 2026.
Abstract Background Metformin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) may reduce the risk of adiposity‐related cancers in patients with type 2 diabetes (T2D). The potential synergistic effects of these treatments on cancer incidence remain unclear, considering their distinct biological mechanisms and their associated effects on body ...
Alex E. Henney   +6 more
wiley   +1 more source

Implication of human papillomavirus-66 in vulvar carcinoma: a case report

open access: yesJournal of Medical Case Reports, 2011
Introduction Vulvar cancer in older women is seldom associated with human papillomavirus infection. Case presentation We present the case of an 80-year-old Greek Caucasian woman with an undetermined obstetric and gynecologic history.
Kartsiounis Vasilios C   +6 more
doaj   +1 more source

Use of topical imiquimod in the treatment of VIN: a case report and review of the literature

open access: yesInternational Journal of Women's Dermatology, 2016
Vulvar intraepithelial neoplasia (VIN) is a premalignant disease of the vulvar squamous epithelium. Standard treatment for VIN lesions is surgical excision.
Chelsea Grimes, BS, MS   +3 more
doaj   +1 more source

HPV-associated vulvar carcinoma with sebaceous differentiation. [PDF]

open access: yesGynecol Oncol Rep, 2023
Kuan I   +4 more
europepmc   +1 more source

The Clinical Management and Outcomes of Two Cases of Vulvar Neoplasms: A Two-Case Study of VIN 3 and Stage IA Vulvar Keratinizing Squamous Cell Carcinoma

open access: yesJournal of Mind and Medical Sciences
Vulvar carcinoma is the fourth most common gynecological cancer, with squamous cell carcinoma being the most frequent type. Vulvar intraepithelial neoplasia (VIN) is a precursor lesion and is strongly associated with human papillomavirus (HPV) infection.
Oana Denisa Balalau   +4 more
doaj   +1 more source

ISUOG Consensus Statement on sonographic assessment of the endometrium: how to perform a gynecological ultrasound scan and report the findings

open access: yes
Ultrasound in Obstetrics &Gynecology, Volume 67, Issue 2, Page 241-258, February 2026.
T.  Van den Bosch   +20 more
wiley   +1 more source

Non-invasive diagnosis of vulvar dysplasia using cervical methylation markers—a case control study

open access: yesBMC Medicine
Background Diagnostic screenings for vulvar squamous intraepithelial lesions (VSIL) are limited and without information on disease trends. A panel of six methylation markers (ASTN1, DLX1, ITGA4, RXFP3, SOX17, ZNF671; GynTect® assay) has shown promise in ...
Sabeth Becker   +7 more
doaj   +1 more source

Vulvar Reconstruction with Keystone Flaps after Radical Vulvectomy

open access: yesPlastic and Reconstructive Surgery, Global Open
Summary:. Vulvar cancer is a rare oncologic pathology, accounting for only 3%–5% of all gynecologic neoplasms, with squamous cell carcinoma responsible for more than 90% of these cases; the remaining 10% includes Paget disease, lichen sclerosus, and ...
Germán Páez López, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy